## One of North America’s largest IRBs

Headquartered in Cincinnati, Ohio, Schulman Associates IRB is an independent institutional review board overseeing the review of research protocols and consent documents used to protect human subjects participating in pharmaceutical, biotech and medical device trials. Schulman was acquired by Imperial Capital in 2008 and was sold in 2014.

# Strategy

ApproachAcquisition

Investment Date2008 – Fund IV

StatusRealized – 2014

HeadquartersCincinnati, OH

SectorHealthcare

MarketsU.S., Puerto Rico and Canada

Imperial Lead Jeffrey Rosenthal Managing Partner

## Your Company, Your Idea, Your Partner

We are always looking for new partnership opportunities and seeking to help build better businesses. If you are the founder of a business that is poised for growth, a seasoned executive that has a great idea for an industry to invest in or an entrepreneur that wants to launch a business, we should talk.

Your request has been sent.

I consent to receive future communications from Imperial Capital.

Welcome to our website! We use cookies to enable some website functionality and to monitor how visitors interact with our website in order to improve the browsing experience. For more information, please review our Cookies and Privacy Policies.

Accept Cookies